Chinook Therapeutics
Why Robinhood?
You can watch KDNY and buy or sell other stocks, ETFs, and their options commission-free!About KDNY
Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA.
KDNY Key Statistics
Stock Snapshot
The current Chinook Therapeutics(KDNY) stock price is $40.39, with a market capitalization of 2.9B. The stock trades at a price-to-earnings (P/E) ratio of -11.49.
During the trading day, Chinook Therapeutics(KDNY) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 1.98M.
The stock's 52-week range extends from a low of $18.34 to a high of $40.51.
The stock's 52-week range extends from a low of $18.34 to a high of $40.51.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.